Our research group conducts a patient-centric translational research program aiming at the identification and validation of novel therapeutic strategies for patients with ACUTE MYELOID LEUKEMIA in preclinical programs.

The Theilgaard-Mönch Group is located at the Finsen Laboratory, a cancer research department at the Finsen Centre at Rigshospitalet, Copenhagen University Hospital.